GSR and ovarian carcinoma: CA possesses a dual mechanism of action, acts as a GSTP1 and GSR1 inducer and as their inhibitor in ovarian carcinoma cells A2780 [140], and CA in these cells before cisplatin treatment induces GST and GR expression [55].